Management of patients with pemphigus vulgaris during the COVID-19 pandemic: Experience of a second level dermatology center

Australas J Dermatol. 2021 Feb;62(1):e158-e159. doi: 10.1111/ajd.13414. Epub 2020 Aug 5.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Australia
  • Biological Factors
  • COVID-19*
  • Consensus
  • Dermatology*
  • Humans
  • New Zealand
  • Pandemics
  • Pemphigus* / drug therapy
  • Pemphigus* / epidemiology
  • SARS-CoV-2

Substances

  • Biological Factors